A synthetic peptide studied in Russia for anxiety. It is said to be registered there, which we could not confirm. Not approved in the EU or US. We have not graded the studies yet. The number of papers in the databases is shown on the page.

PL: No approval. The European medicines database (EMA) lists no such medicine in Poland (9 October 2026). The Polish register was down, so we could not check it directly. EU: No approval. The European medicines database (EMA), which covers EU and national approvals, lists no such medicine (9 October 2026). US: No approval. The FDA drug register has no such medicine.

Short entry. It holds facts from official registers, with no study grade. We are still writing the full description.

Selank

TP-7

A synthetic peptide studied in Russia for anxiety. It is said to be registered there, which we could not confirm. Not approved in the EU or US.

This site is for information and education only. It does not promote or encourage the use or purchase of the substances described and is not medical advice. Many are not authorised as medicines and their safety has not been established. We sell nothing and have no ties to sellers. For health decisions, consult a doctor.

Type: Peptide
Stage: Medicine outside EU and US
Safety: Not known
Doping: May be banned, WADA 2026
Risk of fakes: Medium
Checked: Not yet

Doping. It is not on the WADA list. The ban does not cover substances approved by an authority, and it is said to be approved in Russia, which we could not confirm.

Safety. A 2020 lab paper says that, as far as the authors know, it has not completed any study in people. Sources: study 1.

Risk of fakes. Found in seized products and sold online as powder and nose spray. Nobody checked the contents against a label. Sources: study 1.

Is it legal

Where	Status		Checked
PL	No approval	The European medicines database (EMA) lists no such medicine in Poland (9 October 2026). The Polish register was down, so we could not check it directly. Source	Not yet
EU	No approval	The European medicines database (EMA), which covers EU and national approvals, lists no such medicine (9 October 2026). Source	Not yet
US	No approval	The FDA drug register has no such medicine. Source	Not yet

How much research exists

Scientific papers: 68
Studies with random groups: 2
Registered studies in people: 2

Scientific papers per year 2015–2025

These are search results. A count shows how much exists, not how good the studies are. 1 Nov 2026.

Reported side effects

What doctors, patients and companies reported to the US medicines agency (FDA), and single cases described in medical journals. A report says what happened to someone after taking the substance. It does not prove the substance caused it, and it does not say how often it happens. Reports do not change any grade.

Reports to the FDA (USA)

Reports: 0
Of these, serious: 0

The FDA has no reports. That is not a sign of safety: almost nobody reports substances from outside pharmacies.

Cases described in medical journals

We found no published case of harm.

FDA reports come from openFDA, cases from a PubMed search. The editors have not read these cases yet. Titles stay in the original language. As of 3 Nov 2026.

More papers we found

Studies	Kind of study	Year
[Optimization of the treatment of anxiety disorders with selank].Zh Nevrol Psikhiatr Im S S Korsakova	Random groups	2015
[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].Zh Nevrol Psikhiatr Im S S Korsakova	Random groups	2008
[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zh Nevrol Psikhiatr Im S S Korsakova	No random groups	2014
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.J Am Acad Orthop Surg Glob Res Rev	Review of studies	2026
Tuftsin - Properties and Analogs.Curr Med Chem	Review of studies	2017
[Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application].Izv Akad Nauk Ser Biol	Review of studies	2006
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.Bull Exp Biol Med	In animals	2022
The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress.Curr Rev Clin Exp Pharmacol	In animals	2021

We found these papers automatically in PubMed. The editors have not read them yet, and they do not affect any grade. Titles stay in the original language.

All papers and studies we found (67)

Short answers

Does selank work?: A synthetic peptide studied in Russia for anxiety. It is said to be registered there, which we could not confirm. Not approved in the EU or US. We have not graded the studies yet. The number of papers in the databases is shown on the page.
Is Selank legal?: PL: No approval. The European medicines database (EMA) lists no such medicine in Poland (9 October 2026). The Polish register was down, so we could not check it directly. EU: No approval. The European medicines database (EMA), which covers EU and national approvals, lists no such medicine (9 October 2026). US: No approval. The FDA drug register has no such medicine.
Is selank banned in sport?: May be banned, WADA 2026. It is not on the WADA list. The ban does not cover substances approved by an authority, and it is said to be approved in Russia, which we could not confirm.
Is Selank safe?: Not known. A 2020 lab paper says that, as far as the authors know, it has not completed any study in people.

Plain text for machines